HMOX1 and systemic sclerosis: Our results show that HO-1 plays a role in Ca2+ homeostasis and promotes angiogenesis in SSc, suggesting that promotion of HO-1/CO signaling in early phases of the disease may be a potential therapeutic approach to prevent endothelial dysfunction.